CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
This collection of articles produced by the vendors provides a glimpse of how their products will be addressed on the RSNA exhibit floor, as well as insights to how each compares with the others.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.